The results showed a reduced tumor burden in Juglone‐treated tumor (Figure 6a,b) and immunohistochemistry showed a reduction in PCNA expression of Juglone‐treated tumor (Figure 6c), indicating that Pin1 inhibition inhibits tumor proliferation in vivo. This evidence concerns the gene PIN1 and neoplasm.